Initial therapy for human immunodeficiency virus: broadening the options.

about

Initial therapy for human immunodeficiency virus: broadening the options.

Item

http://www.wikidata.org/entity/Q35759609

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Initial therapy for human immunodeficiency virus: broadening the options.

@ast

Initial therapy for human immunodeficiency virus: broadening the options.

@en

type

Item

label

Initial therapy for human immunodeficiency virus: broadening the options.

@ast

Initial therapy for human immunodeficiency virus: broadening the options.

@en

prefLabel

Initial therapy for human immunodeficiency virus: broadening the options.

@ast

Initial therapy for human immunodeficiency virus: broadening the options.

@en

P1476

Initial therapy for human immunodeficiency virus: broadening the options.

@en

P2093

Michael Sension

http://www.w3.org/2001/XMLSchema#string

P2860

A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active site.

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study.

Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples.

Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy.

Highlights in the development of new antiviral agents.

Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection.

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

P304

99-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1310/0H45-8QWU-FAUD-7E36

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15116286

http://www.w3.org/2001/XMLSchema#string